Bio Special BioInvest

Sun Pharma to Acquire Concert Pharmaceuticals

Adds Deuruxolitinib, a Potential Best-in-Class Oral JAK Inhibitor for the Treatment of Alopecia Areata, an Autoimmune Dermatological Disease Leverage...

 January 20, 2023 | News

Healthcare AI Firm Qritive Raises $7.5M to Expand into New Markets

Qritive (www.qritive.com), a leading healthcare AI startup has announced that they have raised $7.5M in a funding round led by MassMutual Ve...

 January 19, 2023 | News

Speakers Announced for 2023 BIO CEO & Investor Conference

The Biotechnology Innovation Organization (BIO) will hold its CEO & Investor Conference February 6-9, 2023 to bring biotech companies togethe...

 January 18, 2023 | News

Ferrum Health Raises $6 Million to Bring Artificial Intelligence into Healthcare

"We are excited to have the support of Urban Innovation Fund, Singtel Innov8, and Cercano Management in our mission to bring AI to healthcare," said Pelu T...

 January 13, 2023 | News

GE HealthCare Announces Preliminary Fourth Quarter and Full Year 2022 Revenue Results; Introduces 2023 Outlook

GE HealthCare (Nasdaq: GEHC), a leader in precision care innovation, today announced preliminary unaudited revenue results for the fourth quarter and full ...

 January 10, 2023 | News

Danaher CEO to Comment on Financial Performance

For the fourth quarter 2022, estimated revenues are anticipated to increase in the low-single digit percent range year-over-year. The Company expects estim...

 January 10, 2023 | News

Healthcare AI Firm Qritive Raises $7.5M to Expand into New Markets

Qritive (www.qritive.com), a leading healthcare AI startup has announced that they have raised $7.5M in a funding round led by MassMutual Ventures, support...

 January 09, 2023 | News

Parnell Pharmaceuticals Holdings Ltd Announces Extension of Rights Offering

Under the terms of the Rights Offering, Parnell is extending the expiration date to Wednesday, January 11, 2023 at 5:00 PM (Eastern Time)&nb...

 January 09, 2023 | News

BioVersys Extends its Series C Round to CHF 32.6 Million with Investment from the AMR Action Fund

 BioVersys AG, a privately held clinical stage, multi-asset Swiss pharmaceutical company focusing on research and development of therapies for life-th...

 January 06, 2023 | News

Novavax Announces Pricing of its $150 Million Convertible Debenture Offering

The Notes are currently being offered and sold only to persons who are reasonably qualified institutional purchasers within the meaning of Rule 144A under ...

 December 19, 2022 | News

Lilly Announces 15% Dividend Increase, First-Quarter 2023 Dividend

The dividend is payable on March 10, 2023 to shareholders of record at the close of business on Feb. 15, 2023.   Lilly unites caring with ...

 December 13, 2022 | News

Medtronic announces cash dividend for third quarter of fiscal year 2023

This quarterly declaration is consistent with the dividend announcement made by the company in May 2022. Medtronic is a constituent of the S&P 500...

 December 09, 2022 | News

Sartorius agrees with BICO on strategic cooperation as well as a 10 percent capital investment

BICO Group is a pioneer and leading provider of instruments and consumables for bioprinting, bioscience and bioautomation applications in the life scienc...

 December 08, 2022 | News

BRIM Biotechnology, Inc. raises $20 million in Series E funding round

Since the company’s inception in 2013, BRIM has successfully developed several platform technologies, including the regenerative peptide technology (...

 December 05, 2022 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close